Shlomit Strulov Shachar

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

Rashmi K. Murthy, Sherene Loi, Alicia Okines et al. · New England Journal of Medicine · 2019 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +12

Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease

Nina Boulman, Yishai Levy, Ronit Leiba et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 334 citations · Full text

Medicine, Endocrinology, Gynecology +11

Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy

Shlomit Strulov Shachar, Allison M. Deal, Marc S. Weinberg et al. · Clinical Cancer Research · 2016 · 291 citations · Full text

Medicine, Oncology, Pharmacology +17

Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer

Shlomit Strulov Shachar, Allison M. Deal, Marc S. Weinberg et al. · Clinical Cancer Research · 2017 · 159 citations

Medicine, Oncology, Pharmacology +17

Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer

Elizabeth M. Cespedes Feliciano, Wendy Y. Chen, Valerie Lee et al. · JAMA Oncology · 2019 · 116 citations · Full text

Medicine, Oncology, Pharmacology +13